Determining the Role of Point-of-Care Hemoglobin Testing in the Resuscitation of Acutely Hemorrhaging Patients

Authors

Eugene P. Warnick, Thomas Jefferson UniversityFollow
Alexis R. Peedin, MD, Thomas Jefferson UniversityFollow

Document Type

Abstract

Publication Date

5-1-2018

Comments

Honors Program Student Research Symposium (April, 2018)

Sidney Kimmel Medical College, Department of Pathology, Anatomy & Cell Biology

Stephen Peiper, MD, Chair

Program Coordinators: Casey Callahan, BS & Bruce Fenderson, PhD

Funding provided by the "Intersociety Council for Pathology Information"

Abstract

Point-of-care hemoglobin (Hb) testing has not been evaluated in the resuscitation of acutely hemorrhaging patients to guide transfusion therapy. This study assessed the correlation of Hb values determined by point-of-care (EPOC) and traditional laboratory (CBC) methods in patients undergoing massive transfusion. All patients transfused per the massive transfusion protocol (MTP) between February 2013 and October 2017 were identified. The EPOC result was most often within 1 g/dL of the CBC result when EPOC resulted in a Hb between 7-10 g/dL and when drawn within 15 minutes of the CBC specimen. In patients on MTP with an EPOC Hb between 7-10 g/dL, intensivists should feel comfortable making decisions related to transfusion therapy without waiting for the CBC result.

Recommended Citation

Warnick, Eugene P. and Peedin, MD, Alexis R., "Determining the Role of Point-of-Care Hemoglobin Testing in the Resuscitation of Acutely Hemorrhaging Patients" (2018). Department of Pathology Honors Program Student Research Symposium. Poster 34.
https://jdc.jefferson.edu/phsrs/34

Language

English